REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Inmunotech S.A. (Ecuador)

Main Activities: General Medical and Surgical Hospitals
Full name: Inmunotech S.A. Profile Updated: February 10, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Spanish Download a sample report

Inmunotech S.A. is a company in Ecuador, with a head office in Guayaquil. It operates in the General Medical and Surgical Hospitals sector. Inmunotech S.A. was incorporated on June 26, 2020. 5 (2024) employees currently work for Inmunotech S.A.. There was a net sales revenue increase of 29.46% reported in Inmunotech S.A.’s latest financial highlights for 2024. Its total assets grew by 114.99% over the same period. The net profit margin of Inmunotech S.A. decreased by 0.7% in 2024.

Headquarters
Calle 8va, Sertesa Bldg. , Floor 202
Guayaquil; Guayas;

Contact Details: Purchase the Inmunotech S.A. report to view the information.

Basic Information
Total Employees:
Purchase the Inmunotech S.A. report to view the information.
Registered Capital:
Purchase the Inmunotech S.A. report to view the information.
Financial Auditors:
Purchase the Inmunotech S.A. report to view the information.
Incorporation Date:
June 26, 2020
Key Executives
Purchase this report to view the information.
President
Purchase this report to view the information.
General Manager
Ownership Details
Purchase this report to view the information.
50%
Purchase this report to view the information.
50%
Company Performance
Financial values in the chart are available after Inmunotech S.A. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency USD. Absolute financial data is included in the purchased report.
Net sales revenue
29.46%▲
Total operating revenue
31.51%▲
Operating profit (EBIT)
21.41%▲
EBITDA
26.9%▲
Net Profit (Loss) for the Period
6.3%▲
Total assets
114.99%▲
Total equity
41.57%▲
Operating Profit Margin (ROS)
-0.39%▼
Net Profit Margin
-0.7%▼
Return on Equity (ROE)
-9.75%▼
Debt to Equity Ratio
34.46%▲
Quick Ratio
-0.21%▼
Cash Ratio
-0.19%▼

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo